TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Infant receiving exclusively breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants With Axillary Temperature <36.0 Degrees Celsius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants With Axillary Temperature < 36.0 Degrees Celsius at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Vitamin A status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of peak exercise E/E' by diastolic stress echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of global longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of LV vortex flow parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical gastro-intestinal (GI) perforation/fistula events grade ≥ 2
Endpoint domain: Adverse events/effects
Primary endpoint: Pain evaluation at 24 hours post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder Flexion and External Rotation Passive Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative cumulative dose of cabazitaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of GPPA by teeth reaching an EPT of 80
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suicidal Ideation and Behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life and Social/Emotional Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pulse pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in scores from the Global Physical Activity Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prevalence of hospital and ICU Admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Time to treatment failure
Endpoint domain: Adverse events/effects
Primary endpoint: Time to cardiovascular composite primary endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Infant Motor Profile (IMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of the wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural electrical activity of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Passive Emptying of Left Atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Active Emptying of Left Atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Atrial Reservoir Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mattis Dementia Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: global response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOL constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fold-change in Oscillatory Activity (Power Spectral Density)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reoperation for recurrence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Patients With Local Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CD group attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nasal Procedure and Latera™ Device-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Pregnancy outcomes including complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Subject-Reported Ocular Itching Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBA abnormal forms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Glycemic balance (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Predicted histology of polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of ipilimumab and nivolumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total Pain Relief Score (TOTPAR4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closure rate of the target vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Absence of refluxing vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes from Baseline Fasting Plasma LDL Cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Adverse Events following one-month supplementation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse Events following two-months supplementation
Endpoint domain: Adverse events/effects
Primary endpoint: metabolites of arachidonic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight change from baseline to week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PK interaction of amlodipine and valsartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK interaction of atorvastatin and 2-OH atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of Diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acute lower respiratory tract infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days with severe illness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Self-reported Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence of Urinary tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical cure of the lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mycological cure of the lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in fasting insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants With Clinically Important Laboratory Abnormalities With CTCAE Grade 3 or More
Endpoint domain: Adverse events/effects
Primary endpoint: CR+CRh rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyographic activity of the respiratory muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Löe-Silness Gingivitis Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with abnormal serum transaminase levels on the last day of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean serum transaminase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean change in serum transaminase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Memory test battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bulbar hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal staining type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMPs level of coronary sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lung mucociliary clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung cough clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Overall Work Impairment (OWI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Antioxidant enzymes level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in best corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glucose level during oral glucose tolerance test (OGTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Cycloplegic Autorefraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Total Dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With Incidence of Any Bleeding Events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated venous oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants who Achieve a Greater Than or Equal to (>=) 35% Reduction in Spleen Volume from Baseline at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Complete Remission (CR) and Partial Remission (PR) at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of recurrent acute cholecystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cell Yield Per 100ml Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of exfoliation deposits on the lens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia capture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of Tarceva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cellular TBE immunity (cytokine production)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Interested in CAM
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sleep Spindle Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Proportion of modified Rankin Scale responders
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean pressure gradient across the valve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: derived Effective Orifice Area (EOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of anatomical variations of the sphenoid sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of NRS average score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in percent-predicted prebronchodilator FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of diagnostic methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelium-dependent vasodilation capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microbial DNA profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of CD4+ naive T cells (CCR7+CD45RA+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of CD8+ naive T cells (CCR7+CD45RA+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of CD4+ central memory T cells (CCR7+CD45RA-)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of CD8+ central memory T cells (CCR7+CD45RA-)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Treatment Satisfaction measured by DTQ Total Change Score (Micropump vs. MDI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment Satisfaction measured by DTQ Total Change Score (Micropump vs. OmniPod)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone Scan Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cortical Excitability and Activation Patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tau density on PET imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tau distribution on PET imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Invasive Disease-free Survival (iDFS)
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in UPDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients withdrawn due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Arm Activity (ArmA) Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NICU Length of Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Time to acknowledge alert
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visualization of incomplete femur fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Baseline Resilience at 3-6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Baseline Pediatric Quality of Life at 3-6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Baseline Satisfaction with Social Roles at 3-6 months and Activities (v2.0)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Annual Height velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tongue strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue contact duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration vs. time curve in plasma from zero to infinity (AUCu) (unbound)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed (unbound) drug concentration (Cmax,u)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum ALT (Alanine Aminotransferase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Liver Stiffness Measurements by Transient Elastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of fitness sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of breaths with tidal volume 6ml/kg PBW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of directly related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cross-sectional area of gastric antrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood Cortisol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum Lp-PLA2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum SOD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum GPX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antitumor activity (response rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment viral remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Illness Rating Scale for Geriatrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of steps/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum testosterone concentration-time curve from time 0-10 (AUC(0-10))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provider acceptability rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provider rating of feasibility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Provider report of adoption of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Who Were Free of Spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Neonatal linear growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face volume variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature Increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat Conservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients progressing on first line EGFR TKI therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of high resolution diffusion-weighted imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow visible in laser speckle contrast images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving doubling dose improvement in PC20 methacholine or reduction in FEV1 reversibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Routine physical exams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pulmonary postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline Visual Analog Scale for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Six minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms severity of selective mutism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of tobacco counsel
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Major limb amputation rate
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Triglycerides Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in High-Density Lipoprotein Cholesterol (HDL-C) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall response rates (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Remission as assessed by MADRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence rates
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: American Spinal Injury Association (ASIA) Impairment Scale (AIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Diagnostic utilities of biomarkers in diagnosing LONS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic utilities of biomarkers in diagnosing NEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proteinuria (total urinary protein excretion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Recurrence of thrombotic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of de novo GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Acute Muscle Protein Synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response to treatment based on RECIST criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cortical oxy-haemoglobin increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' evaluation of pain and discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Movement Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes